Carly Kenselaar

Item: Carly Kenselaar
Rating: 3.12
Author: StockAnalysis.com

Stock Analyst at Citigroup

(3.12)

# 1,235

Out of 5,012 analysts

Total ratings

100%

Success rate

77.82%

Average return

Main Sectors:

Top Industries:

Stocks Rated by Carly Kenselaar

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	KRYS Krystal Biotech	Maintains: Neutral	$155 → $176	$183.02	-3.84%	2	Jul 10, 2025
	TVTX Travere Therapeutics	Maintains: Buy	$35 → $32	$25.50	+25.49%	6	Jun 11, 2025

Krystal Biotech

Jul 10, 2025

Maintains: Neutral

Price Target: $155 → $176

Current: $183.02

Upside: -3.84%

Travere Therapeutics

Jun 11, 2025

Maintains: Buy

Price Target: $35 → $32

Current: $25.50

Upside: +25.49%